uniQure N.V. QURE Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$21.78 down $0.74, 3.29% at close Oct 16
Last close · Previous close $22.52
- Market cap
- $1.37BAt the Oct 16 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$21.78down $0.74, 3.29%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$22.52Oct 15
- Volume1.29MOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume3.64MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $8.73 to $71.50; now $21.78
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
QURE beat the S&P 500 in 1 of 7 periods.
| Period | QURE and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | QURE: down 48.7% S&P 500: up 1.5% | QURE trailed the S&P 500 by 50.2 percentage points Trailed |
| 3M | QURE: down 44.7% S&P 500: up 1.9% | QURE trailed the S&P 500 by 46.6 percentage points Trailed |
| YTD | QURE: down 9.0% S&P 500: up 12.8% | QURE trailed the S&P 500 by 21.8 percentage points Trailed |
| 1Y | QURE: down 63.7% S&P 500: up 16.8% | QURE trailed the S&P 500 by 80.5 percentage points Trailed |
| Long term | ||
| 3Y | QURE: up 240.8% S&P 500: up 81.5% +50.5% vs +22.0% a year | QURE beat the S&P 500 by 159.3 percentage points Beat |
| 5Y | QURE: down 27.5% S&P 500: up 83.1% −6.2% vs +12.9% a year | QURE trailed the S&P 500 by 110.6 percentage points Trailed |
| 10Y | QURE: up 212.5% S&P 500: up 319.6% +12.1% vs +15.4% a year | QURE trailed the S&P 500 by 107.1 percentage points Trailed |
$10,000 invested in QURE 10 years ago (Oct 14, 2016) would be worth about $31,248 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
QURE beat the S&P 500 in 1 of 7 periods.
| Period | QURE and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | QURE: down 48.7% S&P 500: up 1.2% | QURE trailed the S&P 500 by 49.9 percentage points Trailed |
| 3M | QURE: down 44.7% S&P 500: up 1.7% | QURE trailed the S&P 500 by 46.4 percentage points Trailed |
| YTD | QURE: down 9.0% S&P 500: up 11.9% | QURE trailed the S&P 500 by 20.9 percentage points Trailed |
| 1Y | QURE: down 63.7% S&P 500: up 15.5% | QURE trailed the S&P 500 by 79.2 percentage points Trailed |
| Long term | ||
| 3Y | QURE: up 240.8% S&P 500: up 75.0% +50.5% vs +20.5% a year | QURE beat the S&P 500 by 165.8 percentage points Beat |
| 5Y | QURE: down 27.5% S&P 500: up 71.2% −6.2% vs +11.4% a year | QURE trailed the S&P 500 by 98.7 percentage points Trailed |
| 10Y | QURE: up 212.5% S&P 500: up 258.1% +12.1% vs +13.6% a year | QURE trailed the S&P 500 by 45.6 percentage points Trailed |
$10,000 invested in QURE 10 years ago (Oct 14, 2016) would be worth about $31,248 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$82.19
Closing high on . Now 73.5% below that record.
Split-adjusted daily closes since Feb 5, 2014.
Stock splits
QURE hasn’t split since its price history begins in 2014.
Valuation
Financials
About uniQure N.V.
uniQure N.V., a biopharmaceutical company, develops adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency. It also develops AMT-060, a gene therapy that is in Phase I/II clinical trial for the treatment of hemophilia B; S100A1, a preclinical therapeutic for congestive heart failure; AMT-021, a gene therapy, which has completed Phase I clinical trial for acute intermittent porphyria; AMT-110, a gene therapy that is in Phase I/II clinical trial for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, University of California San Francisco, Bristol-Myers Squibb, and 4D Molecular Therapeutics. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
QURE news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
QURE stock FAQ
What is QURE stock’s price today?
uniQure (QURE) traded at $21.78 at the close on , down $0.74 (3.29%) from the previous close of $22.52. Over the past 52 weeks it has traded between $8.73 and $71.50.
If you invested $1,000 in QURE 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in QURE on would be worth about $3,125 at the close on , a total return of +212.5%. The same $1,000 would be worth $725 if invested five years ago and $363 if invested one year ago. Past performance doesn’t predict future returns.
What is uniQure’s market cap?
uniQure’s market capitalization is about $1.4 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $21.78 (how market cap works).
Does QURE pay a dividend?
uniQure hasn’t paid a dividend in the last twelve months.
What is QURE’s 52-week high and low?
Over the past 52 weeks QURE has traded as low as $8.73 and as high as $71.50. At $21.78 at the close on , it is 69.5% below that high and 149.5% above the low.
What is QURE’s all-time high?
QURE’s highest closing price was $82.19 on , adjusted for stock splits. At $21.78 at the close on , it is 73.5% below that record.
Has QURE stock ever split?
No. QURE hasn’t split since its price history begins in 2014.
How has QURE stock performed?
Including dividends and measured to the close on , QURE has returned −9.0% so far this year and −63.7% over the past year, and −27.5% over five years (−6.2% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What exchange does QURE trade on?
uniQure trades on the Nasdaq under the ticker symbol QURE. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.